Peer review reports
From: ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL
Original Submission | ||
---|---|---|
2 Nov 2017 | Submitted | Original manuscript |
21 Nov 2017 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 2 | ||
21 Nov 2017 | Submitted | Manuscript version 2 |
4 Jan 2018 | Reviewed | Reviewer Report - Khawla Al-Kuraya |
6 Feb 2018 | Reviewed | Reviewer Report - Sung Gwe Ahn |
8 Mar 2018 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 3 | ||
8 Mar 2018 | Submitted | Manuscript version 3 |
25 Mar 2018 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 4 | ||
25 Mar 2018 | Submitted | Manuscript version 4 |
22 Apr 2018 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 5 | ||
22 Apr 2018 | Submitted | Manuscript version 5 |
26 Apr 2018 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 6 | ||
26 Apr 2018 | Submitted | Manuscript version 6 |
27 Apr 2018 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 7 | ||
27 Apr 2018 | Submitted | Manuscript version 7 |
11 May 2018 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 8 | ||
11 May 2018 | Submitted | Manuscript version 8 |
15 May 2018 | Author responded | Author comments - Yu-Lin Wang |
Resubmission - Version 9 | ||
15 May 2018 | Submitted | Manuscript version 9 |
Publishing | ||
18 May 2018 | Editorially accepted | |
29 May 2018 | Article published | 10.1186/s12885-018-4517-0 |